Neutralizing Antibody Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	160 Pages	Coherent Market Insights	June, 2023	CMI18049208

Best Price Guarantee
Price	from $4,500
Length	160 Pages
Publisher	Coherent Market Insights
Published Date	June, 2023
SKU	CMI18049208

Neutralizing Antibody Market, By Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies), By Target Virus (SARS-CoV-2 (COVID-19), HIV, Influenza, Ebola, Zika, Hepatitis C, Others), By Application (Therapeutics, Diagnostics, Research and Development), By End-User (Hospitals and Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical Companies, Others), By Distribution Channel (Direct Sales to End-Users, Distributors, Online Retail, Others), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Neutralizing antibodies are a critical component of our natural immunity and can be induced by both natural infection and vaccination. These antibodies recognize specific parts of the virus and prevent them from binding to and infecting cells. The antibodies’ specialized structure allows them to bind to the receptor binding domain (RBD) on the viral spike protein, preventing it from engaging the host cell’s receptor and facilitating virus entry into the cell.

Market Dynamics:

The global neutralizing antibody market is expected to grow at a rapid growth over the forecast period. One of the key drivers for this growth is the high prevalence of infectious diseases such as hepatitis, HIV, and tuberculosis. The availability of several therapeutic mAbs is another factor driving market growth. In addition, the introduction of advanced technologies for developing mAbs is expected to drive the growth of this market. However, high cost of these tests can limit their adoption, thereby hindering market growth.

Key features of the study:

This report provides in-depth analysis of the global neutralizing antibody market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global neutralizing antibody market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Regeneron Pharmaceuticals, Inc., Eli Lilly and Company, AstraZeneca PLC, GlaxoSmithKline plc, Sanofi SA, Roche Holding AG, Novartis AG, Merck & Co., Inc., Pfizer Inc., Johnson & Johnson, Takeda, Pharmaceutical Company Limited, Moderna, Inc., BioNTech SE, CSL Limited, and Sinovac Biotech Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global neutralizing antibody market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neutralizing antibody market

Detailed Segmentation:

Global Neutralizing Antibody Market, By Antibody Type

Monoclonal Antibodies

Polyclonal Antibodies

Global Neutralizing Antibody Market, By Target Virus

SARS-CoV-2 (COVID-19)

HIV

Influenza

Ebola

Zika

Hepatitis C

Others

Global Neutralizing Antibody Market, By Application

Therapeutics

Diagnostics

Research and Development

Global Neutralizing Antibody Market, By End User

Hospitals and Clinics

Research Institutes

Diagnostic Laboratories

Pharmaceutical Companies

Others

Global Neutralizing Antibody Market, By Distribution Channel

Direct Sales to End-Users

Distributors

Online Retail

Others

Global Neutralizing Antibody Market, By Region

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

Company Profiles

Regeneron Pharmaceuticals, Inc.

Eli Lilly and Company

AstraZeneca PLC

GlaxoSmithKline plc

Sanofi SA

Roche Holding AG

Novartis AG

Merck & Co., Inc.

Pfizer Inc.

Johnson & Johnson

Takeda Pharmaceutical Company Limited

Moderna, Inc.

BioNTech SE

CSL Limited

Sinovac Biotech Ltd.

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Antibody Type; Market Snapshot, By Target Virus; Market Snapshot, By Application; Market Snapshot, By End User; Market Snapshot, By Distribution Channel; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; High prevalence of infectious diseases such as hepatitis, HIV, and tuberculosis; High cost of these tests; Introduction of advanced technologies for developing mAbs; Impact Analysis; Key Highlights; Regulatory Scenario; Product launch/Approvals; PEST Analysis; PORTER’s Analysis; Merger and Acquisition Scenario
4. Global Neutralizing Antibody Market – Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply Side and Demand Side Analysis; Economic Impact
5. Global Neutralizing Antibody Market , By Antibody Type, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Monoclonal Antibodies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Polyclonal Antibodies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
6. Global Neutralizing Antibody Market , By Target Virus, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; SARS-CoV-2 (COVID-19); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); HIV; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Influenza; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Ebola; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Zika; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Hepatitis C; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
7. Global Neutralizing Antibody Market , By Application, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Therapeutics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Diagnostics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Research and Development; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
8. Global Neutralizing Antibody Market , By End User, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Hospitals and Clinics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Research Institutes; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Diagnostic Laboratories; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Pharmaceutical Companies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
9. Global Neutralizing Antibody Market , By Distribution Channel, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Direct Sales to End-Users; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Distributors; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Online Retail; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); 10. Global Neutralizing Antibody Market , By Region, 2023-2030, (US$ Bn); Introduction; Market Share Analysis, By Country, 2023 and 2030 (%); Y-o-Y Growth Analysis, For Country 2018 –2030; Country Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Region, 2023-2030,(US$ Bn); Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Region, 2023-2030,(US$ Bn); Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Region, 2023-2030,(US$ Bn); Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Region, 2023-2030,(US$ Bn); Middle East & Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Region, 2023-2030,(US$ Bn); 11. Competitive Landscape; Regeneron Pharmaceuticals, Inc.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Eli Lilly and Company; AstraZeneca PLC; GlaxoSmithKline plc; Sanofi SA; Roche Holding AG; Novartis AG; Merck & Co., Inc.; Pfizer Inc.; Johnson & Johnson; Takeda Pharmaceutical Company Limited; Moderna, Inc.; BioNTech SE; CSL Limited; Sinovac Biotech Ltd.; Analyst Views; 12. Section; Research Methodology; About us; *Browse 24 market data tables and 28 figures on "Global Neutralizing Antibody Market” - Global forecast to 2030